Related references
Note: Only part of the references are listed.Homocysteine and holotranscobalamin and the risk of Alzheimer disease A longitudinal study
B. Hooshmand et al.
NEUROLOGY (2010)
Enhancement of Learning and Memory by Elevating Brain Magnesium
Inna Slutsky et al.
NEURON (2010)
Hyperhomocysteinemia Increases beta-Amyloid by Enhancing Expression of gamma-Secretase and Phosphorylation of Amyloid Precursor Protein in Rat Brain
Chang-E Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus
Chang-E Zhang et al.
NEUROBIOLOGY OF AGING (2008)
Activation of glycogen synthase kinase-3 inhibits LongTerm Potentiation with synapse-associated impairments
Ling-Qiang Zhu et al.
JOURNAL OF NEUROSCIENCE (2007)
Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway
Kusum K. Kharbanda et al.
JOURNAL OF HEPATOLOGY (2007)
Modulation of the homocysteine-betaine relationship by methylenetetrahydrofolate reductase 677 C-> T genotypes and B-vitamin status in a large-scale epidemiological study
Pal I. Holm et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death
Nicholas K. Gonatas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels
Javier Pacheco-Quinto et al.
NEUROBIOLOGY OF DISEASE (2006)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice
D Terwel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The importance of neuritic plaques and tangles to the development and evolution of AD
P Tiraboschi et al.
NEUROLOGY (2004)
Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease:: Stereologic analysis of prefrontal cortex area 9
T Bussière et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Reconstitution of γ-secretase activity
D Edbauer et al.
NATURE CELL BIOLOGY (2003)
Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria
BC Schwahn et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Identity and function of gamma-secretase
WT Kimberly et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats
L Sun et al.
NEUROSCIENCE (2003)
Tau function and dysfunction in neurons - Its role in neurodegenerative disorders
J Avila et al.
MOLECULAR NEUROBIOLOGY (2002)
Homocysteine and methylenetetrahydrofolate reductase genotype:: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters
D Rothenbacher et al.
ATHEROSCLEROSIS (2002)
γ-Secretase, notch, Aβ and Alzheimer's disease:: Where do the presenilins fit in?
SS Sisodia et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.
S Seshadri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
An open-label, 24-week pilot study of the methyl donor betaine in Alzheimer disease patients
D Knopman et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2001)